nach oben

Wiener Medizinische Wochenschrift

Erschienen in:

23.06.2022 | letter to the editor

Post-SARS-CoV-2 vaccination COVID toes and fingers

Two case reports and a short literature review

verfasst von: Prof. Dr. Uwe Wollina

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 11-12/2023

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Vorheriger Artikel Anti-MDA5 antibody-positive dermatomyositis with mild encephalopathy with reversible splenial lesion: a possible rare association?

Nächster Artikel Post-SARS-CoV-2 vaccination COVID toes and fingers correspondence

Wollina U, Chiriac A, Kocic H, et al. Cutaneous and hypersensitivity reactions associated with COVID-19 vaccination‑a narrative review. Wien Med Wochenschr. 2022;172(3–4):63–9.CrossRefPubMed

Ganatra B, Amarnani R, Alfallouji Y, et al. Patient characteristics in tardive COVID-19 pseudoperniosis: a case series of 16 patients. Clin Exp Dermatol. 2022;47(2):399–403.CrossRefPubMed

Molaee H, Emadi SN, Imunya MJMN, et al. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: a systematic review of articles. Dermatol Ther. 2022;35(3):e15298.CrossRefPubMed

McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases. J Am Acad Dermatol. 2021;85(1):46–55.CrossRefPubMedPubMedCentral

Lesort C, Kanitakis J, Donzier L, Jullien D. Chilblain-like lesions after BNT162b2 mRNA COVID-19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARSCoV‑2. J Eur Acad Dermatol Venereol. 2021;35(10):e630–2.CrossRefPubMedPubMedCentral

Kelso JM, Coda AB, Keating RM, Vaccari DM. “COVID toes” after mRNA COVID-19 vaccines. J Allergy Clin Immunol Pract. 2021;9(8):3196–7.CrossRefPubMedPubMedCentral

Davido B, Mascitti H, Fortier-Beaulieu M, et al. ‘Blue toes’ following vaccination with the BNT162b2 mRNA COVID-19 vaccine. J Travel Med. 2021;28(4):taab24.CrossRefPubMed

Cameli N, Silvestri M, Mariano M, et al. Pernio-like skin lesions after the second dose of Pfizer-BioNTech COVID-19 vaccine. J Eur Acad Dermatol Venereol. 2021;35(11):e725–e7.CrossRefPubMedPubMedCentral

Qiao JW, Dan Y, Wolf ME, et al. Post-vaccination COVID toes (chilblains) exacerbated by [1093] rituximab infusion suggests interferon activation as mechanism. Mil Med. 2021; https://doi.org/10.1093/milmed/usab314.CrossRef

10.

Van Loon A, Mortelmans D, Siozopoulou V, et al. A first case of ‘Covid toes’ from a viral vectorbased COVID-19 vaccine. J Eur Acad Dermatol Venereol. 2022; https://doi.org/10.1111/jdv.17948.CrossRefPubMed

11.

Lopez S, Vakharia P, Vandergriff T, et al. Pernio after COVID-19 vaccination. Br J Dermatol. 2021;185(2):445–7.CrossRefPubMedPubMedCentral

12.

Pérez-López I, Gil-Villalba A, Ruiz-Villaverde R. Perniosis-like lesions after vaccination with mRNA against COVID-19. Med Clin (Barc). 2022;158(4):189–90.CrossRefPubMed

13.

Pileri A, Guglielmo A, Raone B, Patrizi A. Chilblain lesions after COVID-19 mRNA vaccine. Br J Dermatol. 2021;185(1):e3.CrossRefPubMedPubMedCentral

Titel: Post-SARS-CoV-2 vaccination COVID toes and fingers
Two case reports and a short literature review
verfasst von: Prof. Dr. Uwe Wollina
Publikationsdatum: 23.06.2022
Verlag: Springer Vienna
Erschienen in: Wiener Medizinische Wochenschrift / Ausgabe 11-12/2023
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI: https://doi.org/10.1007/s10354-022-00944-z

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11-12/2023

Mikrokannuläre Liposuktion in Tumeszenzanästhesie beim Lipödem: Eine Analyse von 519 Liposuktionen

Anaphylactic reaction to carboplatin diagnosed by skin testing—a reliable tool in platinum-based immediate-type hypersensitivity reactions

Malignant melanoma in a patient with hidrotic ectodermal dysplasia

Onychomadesis in a COVID-19 patient

Response to R. Mungmumpuntipanip and V. Wiwantikit

Giant cell epulis